Related Experiment Videos
Hypertriglyceridemia in diabetes. An approach to management
1Department of Medicine, University of Florida College of Medicine, Gainesville.
The Journal of the Florida Medical Association
|November 1, 1991
Summary
Hypertriglyceridemia management in Type II diabetes involves diet and glycemic control, followed by medications like gemfibrozil or niacin. Patient compliance is key for sustained improvement in triglyceride levels.
Area of Science:
- Endocrinology
- Cardiology
- Metabolic Disorders
Background:
- Hypertriglyceridemia is common in Type II diabetes, often linked with coronary heart disease and inherited hyperlipidemias.
- Diabetic control significantly impacts triglyceride levels, even in severe cases.
- Unlike hypercholesterolemia, specific guidelines for hypertriglyceridemia treatment are lacking.
Purpose of the Study:
- To outline an effective treatment algorithm for hypertriglyceridemia in diabetic patients.
- To highlight the roles of lifestyle modifications and pharmacotherapy.
Main Methods:
- Emphasis on optimizing dietary and glycemic control as the primary step.
- Introduction of pharmacologic agents including gemfibrozil, niacin, fish oils, and lovastatin.
- Assessment of treatment efficacy based on triglyceride and HDL-cholesterol levels.
Main Results:
- Dietary and glycemic control markedly improve triglyceride levels.
- Gemfibrozil and niacin effectively reduce triglycerides and increase HDL-cholesterol.
- Lovastatin primarily targets LDL-cholesterol reduction.
Conclusions:
- A stepwise approach combining lifestyle changes and targeted medications can successfully manage hypertriglyceridemia in diabetics.
- Sustained patient compliance is crucial for long-term therapeutic success.